Chicago Partners Investment Group LLC Iovance Biotherapeutics, Inc. Transaction History
Chicago Partners Investment Group LLC
- $2.81 Billion
- Q4 2024
A detailed history of Chicago Partners Investment Group LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 20,559 shares of IOVA stock, worth $115,952. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,559
Previous 20,559
-0.0%
Holding current value
$115,952
Previous $193,000
21.24%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding IOVA
# of Institutions
319Shares Held
243MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$154 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$150 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$135 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$120 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$74.5 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $890M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...